A targeted behavioural economics-based intervention to improve medication adherence in patients with Hypertension: the BEHAVE-HTN study protocol
Authors:
- Annina S. VischerAnnina S. Vischer
- Jan StrebelJSJan Strebel
- Anjali Raja BeharelleABAnjali Raja Beharelle
- Michael MayrMMMichael Mayr
- Valeriya NemtsovaVNValeriya Nemtsova
- Gregoire WuerznerGWGregoire Wuerzner
- Georg EhretGEGeorg Ehret
- Michael StiefelMSMichael Stiefel
- Emrush RexhajEREmrush Rexhaj
- Théo MeisterTMThéo Meister
- Thilo BurkardTBThilo Burkard
Preprint
Abstract
Background and Aims: Non-adherence to antihypertensive therapy is a major contributor to poor blood pressure (BP) control, increased cardiovascular risk, and higher healthcare costs. Behavioral economics suggests that financial incentives and mobile-based interventions may support behavior change, yet evidence for such strategies in central Europe is limited. Objective: The BEHAVE-HTN study evaluates whether a multi-faceted medication adherence mobile application (mApp) with behavioral economic principles—including reminders, gamification, and financial incentives—improves medication adherence in patients with hypertension compared to standard of care. Methods: This multi-center, randomized, open-label trial will include 180 outpatients with hypertension taking four or more pills daily. Participants will be randomized into three groups (n = 60 per group): (A) mApp with contingent financial incentives, (B) mApp without incentives, and (C) standard of care. All participants will receive a Medication Event Monitoring System (MEMS) dispenser to objectively track adherence. The primary endpoint is the difference in mean MEMS adherence between group A and the control group at 90 days. A co-primary endpoint compares MEMS adherence in the final vs. initial month of the intervention. Secondary outcomes include changes in BP, app-reported adherence, and patient-reported feedback on the mApp. Results: Currently, participant inclusion has been nearly completed. We are undergoing data clearing and are planning data analysis. These steps are planned for autumn 2025. Conclusion: This study will provide evidence on whether a multi-faceted medication adherence mobile App — with or without financial incentives—can improve medication adherence in hypertensive patients. The findings may support the implementation of mobile health strategies in routine hypertension care. Trial Registration: SNCTP000004345; ClinicalTrials.gov Identifier: NCT04708756Keywords
This publication has 43 references indexed in Scilit:
- Mobile Health Applications and Medication Adherence of Patients With Hypertension: A Systematic Review and Meta-AnalysisAmerican Journal of Preventive Medicine, 2022
- Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled TrialApplied Health Economics and Health Policy, 2019
- Interventions for enhancing medication adherenceCochrane Database of Systematic Reviews, 2014
- Bayesian estimation supersedes the t test.Journal of Experimental Psychology: General, 2013
- Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 PatientsThe American Journal of Medicine, 2012
- Medication Adherence to Multidrug RegimensClinics in Geriatric Medicine, 2012
- Reminder packaging for improving adherence to self-administered long-term medicationsCochrane Database of Systematic Reviews, 2011
- Why psychologists must change the way they analyze their data: The case of psi: Comment on Bem (2011).Journal of Personality and Social Psychology, 2011
- How are habits formed: Modelling habit formation in the real worldEuropean Journal of Social Psychology, 2009
- Advances in prospect theory: Cumulative representation of uncertaintyJournal of Risk and Uncertainty, 1992